drugset / Trial / NCT07683793
A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male Participants
NaSequentialOpen-labelTreatment
Summary
This Phase 1 study evaluates the effect of pantoprazole (a proton pump inhibitor) on the pharmacokinetics (PK) of CHF10196 (Florensocatib) in healthy male participants. Participants receive CHF10196 alone and in combination with pantoprazole to assess potential drug-drug interaction (DDI) effects on systemic exposure.
Timeline
- Start
- 2026-10-14
- Primary completion
- 2026-12-09
- Completion
- 2026-12-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CHF10196 | Unknown | — | — |
| Subject | Pantoprazole | Other / unclassified | — | — |
Indications
No indication recorded.